Fierce Pharma

MAY 24, 2024

While it’s hard to overstate the success Novo Nordisk’s GLP-1 franchise has already achieved, the company’s latest deep dive into semaglutide data in chronic kidney disease (CKD) could help set a n | Early Friday, Novo shared full, positive results from the FLOW trial assessing the ability of once-weekly semaglutide 1.0 mg to help combat major kidney outcomes such as kidney failure, loss of kidney function and death from kidney or cardiovascular causes in people with Type 2 diabetes and chronic

Patients 318

Patients 318

MedCity News

MAY 24, 2024

Allegheny Health Network rolled out a large language model designed exclusively for use by its staff members. You can think of the tool as the health system’s own version of Chat-GPT, said Ashis Barad, AHN’s chief digital and information officer. The post Why Allegheny Health Network Created Its Own Chat-GPT For Employees appeared first on MedCity News.

Networking 121

Networking Healthcare Healthcare 121

Fierce Pharma

MAY 24, 2024

In a change of pace from the recent COVID-related business struggles for Pfizer, the drugmaker has picked up a valuable reward from the FDA in the form of a priority review voucher (PRV). | The FDA awarded the voucher based on Paxlovid's status as a countermeasure to a material medical threat, according to a notice in the Federal Register.

FDA 291

FDA Sales Medical 291

pharmaphorum

MAY 24, 2024

AffyImmune Therapeutics has recorded what it says is the first documented complete response in a patient with a solid tumour treated with CAR-T therapy. The case comes from a phase 1 study of its ICAM-1 targeting CAR-T autologous candidate AIC100 in patients with relapsed/refractory poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC), which will be reported at the ASCO congress next week.

Patients 108

Patients 108

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

MAY 24, 2024

AstraZeneca's CEO wants to tap into China's innovation explosion. The company inked an oncology antibody deal with Harbour BioMed, and it plans to build a $1.5 billion ADC plant in Singapore. | AstraZeneca's CEO wants to tap into China's innovation explosion. The company inked an oncology antibody deal with Harbour BioMed, and it plans to build a $1.5 billion ADC plant in Singapore.

FDA 188

FDA Pharma 188

European Pharmaceutical Review

MAY 24, 2024

UCB has announced positive results from the first Phase III trials evaluating the efficacy and safety of an IL-17A and IL–17F inhibitor to treat adults with moderate-to-severe hidradenitis suppurativa. Humanised IgG1 monoclonal antibody (mAb) BIMZELX ® (bimekizumab-bkzx) selectively binds to IL-17A, IL-17F, and IL-17AF cytokines. This inhibits their interaction with the IL-17RA/IL-17RC receptor complex, UCB explained.

Patients 98

Patients Medical Safety Medicine 98

pharmaphorum

MAY 24, 2024

This week’s round-up of biotech financings is led by a $120 million round for UK-based antibody-drug conjugate (ADC) developer Pheon, with SixPeaks also pulling in nine figures and smaller rounds for Progentos, LabGenius, and Grey Wolf, and Imvax.

98

98

MedCity News

MAY 24, 2024

Virtual observation programs can help improve care, help better staff units, and help give nurses the support they need. The post Next-Generation Nursing appeared first on MedCity News.

102

102

Pharmaceutical Technology

MAY 24, 2024

The US FDA's EMDAC is set to hold a meeting to assess the benefit-risk profile of Novo Nordisk's insulin icodec, to treat type 1 diabetes.

FDA 98

FDA 98

MedCity News

MAY 24, 2024

Lyra Care for Teens will be available starting in June. Patients will gain access to therapists who specialize in evidence-based treatments and personalized digital lessons. The post Lyra Health Announces Mental Health Offering for Teens appeared first on MedCity News.

Specialization 100

Specialization Patients 100

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PharmaTech

MAY 24, 2024

With this acquisition, Merck KGaA will have the capability to offer integrated services for viral vector manufacturing.

Manufacturing 96

Manufacturing 96

pharmaphorum

MAY 24, 2024

NICE and NHS England are seeking feedback on proposed new rules and commissioning principles for medtech products.

102

102

PharmaTimes

MAY 24, 2024

The lifelong autoimmune disease affects more than 150,000 people living in the UK

Doctors 112

Doctors Training Management 112

pharmaphorum

MAY 24, 2024

Shares in Merus spike on ASCO abstract on phase 2 trial of EGFRxLGR5 bispecific petosemtamab in head and neck cancer.

98

98

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

MAY 24, 2024

Eli Lilly says its capital commitment to its new Indiana site is the largest manufacturing investment in the company’s history. The site will make tirzepatide, the active pharmaceutical ingredient in both Zepbound and Mounjaro. The post Eli Lilly Pumps $5.3B More Into Site for Making Metabolic Meds Zepbound & Mounjaro appeared first on MedCity News.

Manufacturing 66

Manufacturing Pharmaceutical Biopharma Pharma 66

PharmaTimes

MAY 24, 2024

The conference will take place on 23 to 24 October at Vienna AirportCity

Pharmaceutical 98

Pharmaceutical 98

Pharmaceutical Technology

MAY 24, 2024

Shares in Merus rose by 15% in premarket trading, following the announcement of positive Phase II data to be presented at ASCO.

72

72

Penrod

MAY 24, 2024

An online booking platform enables patients to schedule medical appointments efficiently and conveniently, alleviating the workload on your front office. However, merely having an online presence might not suffice in today’s competitive healthcare market. Your appointment forms likely need optimization. Improving your existing forms with a focus on conversion rates can lead to more patients and growing revenue.

Healthcare 52

Healthcare Healthcare Patients Electronics 52

Advertisement

Scott Burrows

MAY 24, 2024

A few weeks ago, I had the incredible opportunity to tee off at the prestigious Medalist Golf Club in Jupiter, Florida. As I made my way down the manicured fairways and navigated the challenging greens, I couldn’t help but feel a sense of awe knowing that I was playing on the same course frequented by golf legends like Tiger Woods and Rory McIlroy.

Specialization 52

Specialization Media 52

Penrod

MAY 24, 2024

1. Inefficient Appointment Scheduling An inefficient appointment scheduling system can lead to long wait times, double booking, and limited appointment availability, frustrating your existing and potential patients. These issues can disrupt the flow of your practice, causing dissatisfaction and potentially leading to a loss of patients. To solve this problem, you need a comprehensive booking system that offers consistency at each intake location.

Healthcare Provider 52

Healthcare Provider Healthcare Healthcare Patients 52

PharmaTimes

MAY 24, 2024

JHU083 reduced tumour growth and triggered tumour cell death in mice

85

85

PharmaTech

MAY 24, 2024

With the acquisition, Biogen gains felzartamab, HI-Bio's lead investigational mAb candidate being developed for the treatment of a range of immune-mediated diseases.

Leads 52

Leads 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Technology

MAY 24, 2024

The EC has approved Celltrion’s Omlyclo, an omalizumab biosimilar for reference product Xolair to treat allergic conditions.

59

59

PharmExec

MAY 24, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmaceutical Technology

MAY 24, 2024

The clinical-stage biotech will share preliminary safety and efficacy data with its ADC at the 2024 ASCO meeting.

Safety 59

Safety 59

PharmExec

MAY 24, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Healthcare 52

Healthcare Healthcare 52

Advertisement

Distribution

Pharmaceutical Technology

MAY 24, 2024

Grey Wolf Therapeutics has concluded an oversubscribed $50m in Series B financing expansion to advance its antigen modulation technology.

52

52

PharmExec

MAY 24, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Patients 52

Patients Pharma 52

Pharmaceutical Technology

MAY 24, 2024

Affecting more than 162,000 patients worldwide, global clinical trials are researching innovative new treatments for cystic fibrosis.

Patients 52

Patients 52

Pharmacy Times

MAY 24, 2024

The role of semaglutide as a glucagon-like peptide-1 (GLP-1) receptor antagonist could offer further treatment options to improve patient outcomes.

Patients 60

Patients 60

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales